Mendus - Pharma development company focused on preventing cancer recurrence

Mendus började rekrytera patienter till CADENCE-studien under det andra kvartalet 2024.

Mendus Q2’24 resultatförhandsvisning:

Mendus will release its Q2 results on Friday, August 23, at 08:00 am CEST. The live Q2 presentation and business update can be viewed here.

2 gillningar